RegeneRX Biopharmaceuticals Owners

Health Care & Life Sciences » Biotechnology | RegeneRX Biopharmaceuticals Inc.

RegeneRX Biopharmaceuticals Inc. | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Williams, Jones & Associates LLC

150,000

0.12%

06/30/2018

Dumont & Blake Investment Advisors LLC

22,300

0.02%

06/30/2018

Invesco Capital Management LLC

17,879

0.02%

09/05/2018

View Profile

Address	15245 Shady Grove Road Rockville Maryland 20850 United States
Employees	-
Website	http://www.regenerx.com
Updated	07/08/2019
RegeneRx Biopharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, or Tß4, for tissue and organ protection, repair, and regeneration. The firm evaluates the commercial development of peptide fragments and derivatives of Tß4 for potential cosmeceutical and other personal care uses. Its products include RGN-259, RGN-352, and RGN-137.